Skip to main content

Southampton, Oxford Lands $6.3M Grant for Synthetic Biology

NEW YORK (GenomeWeb News) – Researchers at the University of Southampton and the University of Oxford have netted a £4 million ($6.3 million) grant from the Biotechnology and Biological Sciences Research Council to develop a new synthetic biology technology that could aid in the production of useful DNA and RNA structures.

The team will use the funding, awarded under the strategic Longer and Larger program, to develop a technique for "clicking" DNA and RNA segments together that could make synthetic biology research projects cheaper, more efficient, and more scalable, BBSRC said this week.

The technology aims to address one of the difficulties of synthesizing DNA molecules that makes it slow and laborious — the development of large numbers of short DNA strands that are linked together using delicate enzymes. The "click" technique replaces those enzymes with chemical methods to create stronger links between DNA and RNA that make them more useful for industrial scale applications, according to Southampton professor Tom Brown, a joint leader on the project.

"This new technology is an important addition to the toolbox of molecular techniques that is allowing researchers to explore how biological systems function by creating simplified and modified biomolecular machinery," Andrew Turberfield, a professor at Oxford who is participating on the project, said in a statement.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.